Exact Mass: 658.2805
Exact Mass Matches: 658.2805
Found 204 metabolites which its exact mass value is equals to given mass value 658.2805
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Gluten exorphin B5
Gluten exorphin B5 is a pentapeptide with the sequence Tyr-Gly-Gly-Trp-Leu. Gluten exorphins are a group of opioid peptides which are formed during digestion of the gluten protein. It has been hypothesized that people with autism and schizophrenia have abnormal leakage from the gut of these compounds, which then pass into the brain and disrupt brain function. This is partly the basis for the gluten-free, casein-free diet. The scientific evidence for this diet and its effects is still disputed.
(8S,9R,11S,13S,14S,17S)-13-Methyl-11-[4-[5-(4,4,5,5,5-pentafluoropentylsulfonyl)pentoxy]phenyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3,12-O-beta-D-diglucopyranosyl-11,16-dihydroxyabieta-8,11,13-triene
(25S)-spirost-5-ene-1beta,3beta,7beta-triol 1-O-(4-O-sulfo)-R-L-arabinopyranoside|angudracanoside E
(2R,3R,4S,2R)-1-[2,3,4,5-tetrahydro-2-methoxycarbonyl-2-(4-methoxyphenyl)-6-methoxy-7,8-methylenedioxy-5-oxo-3-phenyl-1-benzoxepin-4-carbonyl]-2-(3-methylpropanoylamino)-pyrrolidine|thapoxepine B
1-O-{beta-D-quinovopyranosyl-(1->2)-beta-D-fucopyranosyl-(1->4)-[beta-D-fucopyranosyl(1->2)]-beta-D-quinovopyranosyl}butanol
cephalancetine D|rel-(1R,3aS,5R,14bR)-1-hydroxy-5-[(1S,11R,12R,13S,15R,18R)-12-hydroxy-13-methoxy-5,7,21-trioxa-19-azahexacyclo[11.7.1.02,10.04,8.011,15.015,19]henicosa-2(10),3,8-trien-18-yl]-2-methoxy-1,4,5,8,9,14b-hexahydro-6H-cyclopenta[a][1,3]dioxolo[4,5-h]pyrrolo[2,1-b][3]benzazepin-6-one
5alpha,8beta,11beta,15alpha-tetraacetoxy-3beta-benzoyloxy-9alpha,16beta-dihydroxypepluane
5,8,9,14-Tetraacetoxy-3-benzoyloxy-10,15-dihydroxypepluane
1-O-decanoyl-2,6-di-O-(beta-D-glucopyranosyl)-beta-D-glucopyranose|2,6-di-O-(beta-D-glucopyranosyl)-1-O-decanoyl-beta-D-glucopyranose|nonioside F
3,15-O-diacetyl-7-14-O-dibenzoyl-5-hydroxymyrsinol
His Met Trp Trp
His Trp Met Trp
His Trp Trp Met
Lys Trp Tyr Tyr
Lys Tyr Trp Tyr
Lys Tyr Tyr Trp
Met His Trp Trp
Met Trp His Trp
Met Trp Trp His
Gln Trp Tyr Tyr
Gln Tyr Trp Tyr
Gln Tyr Tyr Trp
Trp His Met Trp
Trp His Trp Met
Trp Lys Tyr Tyr
Trp Met His Trp
Trp Met Trp His
Trp Gln Tyr Tyr
Trp Trp His Met
Trp Trp Met His
Trp Tyr Lys Tyr
Trp Tyr Gln Tyr
Trp Tyr Tyr Lys
Trp Tyr Tyr Gln
Tyr Lys Trp Tyr
Tyr Lys Tyr Trp
Tyr Gln Trp Tyr
Tyr Gln Tyr Trp
Tyr Trp Lys Tyr
Tyr Trp Gln Tyr
Tyr Trp Tyr Lys
Tyr Trp Tyr Gln
Tyr Tyr Lys Trp
Tyr Tyr Gln Trp
Tyr Tyr Trp Lys
Tyr Tyr Trp Gln
4-((4-(6-(Acryloyloxy)hexyloxy)phenoxy)carbonyl)phenyl 4-(6-(acryloyloxy)hexyloxy)benzoate
Naquotinib mesylate
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
Estra-1,3,5(10)-triene-3,17-diol, 11-[4-[[5-[(4,4,5,5,5-pentafluoropentyl)sulfonyl]pentyl]oxy]phenyl]-, (11beta,17beta)-
NVP-CGM097
NVP-CGM097 is a potent and selective MDM2 inhibitor with IC50 of 1.7±0.1 nM for hMDM2.
2-{[4-hydroxy-2-(1-hydroxypropan-2-yl)-4b,8,8-trimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6,7,8a,9,10-hexahydrophenanthren-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
4-[(2s,4r,4as,6ar,8s,10as,10bs)-8-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-7,7,10a-trimethyl-decahydro-1h-naphtho[2,1-c]pyran-2-yl]-5h-furan-2-one
(2z)-4-[(1s,2s,8r,17s,19r)-12-hydroxy-17-methoxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4,6(11),9,12,15-pentaen-19-yl]-2-methylbut-2-enoic acid
3-(8-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-4-hydroxy-7,7,10a-trimethyl-decahydro-1h-naphtho[2,1-c]pyran-2-yl)-5h-furan-2-one
3-[(3s,6r,9r,12r,13r,14r)-5,8,11,13-tetrahydroxy-3-(hydroxymethyl)-6-(1h-indole-3-carbonyl)-12-methyl-14-octyl-2-oxo-1-oxa-4,7,10-triazacyclopentadeca-4,7,10-trien-9-yl]propanoic acid
3-[5,8,11,13-tetrahydroxy-3-(hydroxymethyl)-6-(1h-indole-3-carbonyl)-12-methyl-14-octyl-2-oxo-1-oxa-4,7,10-triazacyclopentadeca-4,7,10-trien-9-yl]propanoic acid
n-[(2r)-1-[(11r,12r,13s)-2-methoxy-11-(methoxycarbonyl)-11-(4-methoxyphenyl)-14-oxo-12-phenyl-4,6,10-trioxatricyclo[7.5.0.0³,⁷]tetradeca-1,3(7),8-triene-13-carbonyl]pyrrolidin-2-yl]-2-methylpropanimidic acid
(1s,2r,3r,4as,4br,7r,10ar)-7-ethenyl-2,3-dihydroxy-1,4a,7-trimethyl-1-({[(2r,3s,4r,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)-2,3,4,4b,5,6,10,10a-octahydrophenanthren-9-one
(3ar,4r,6ar,8s,9ar,9br)-3,6,9-trimethylidene-2-oxo-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[2-(4-hydroxyphenyl)acetyl]oxy}methyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-4-yl (2r)-2-hydroxy-3-methylbutanoate
5,15-bis(3,5-dihydroxy-6-methyloxan-2-yl)-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1³,⁶.1⁸,¹¹.1¹³,¹⁶]tetracosa-1,3(24),6,8,10,12,16(22),17,19-nonaene-4,14-dione
12- o -acetylazedarachin a
{"Ingredient_id": "HBIN000913","Ingredient_name": "12- o -acetylazedarachin a","Alias": "NA","Ingredient_formula": "C35H46O12","Ingredient_Smile": "CCC(C)C(=O)OC1C2(C3CC(C4(C(C3(CO1)C(CC2OC(=O)C)O)C(=O)C(C5(C46C(O6)CC5C7=COC=C7)C)OC(=O)C)C)O)C","Ingredient_weight": "658.73","OB_score": "NA","CAS_id": "157750-73-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9377","PubChem_id": "101930512","DrugBank_id": "NA"}